Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
Pseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a pre...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
_version_ | 1826303833690603520 |
---|---|
author | De Silva, B Banney, L Uttley, W Luqmani, R Schofield, O |
author_facet | De Silva, B Banney, L Uttley, W Luqmani, R Schofield, O |
author_sort | De Silva, B |
collection | OXFORD |
description | Pseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a prevalence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, independent of dosage. Blue/gray eye color was an independent risk factor for the development of pseudoporphyria. We would advise caution in prescribing naproxen in these children to prevent disfiguring facial scarring. |
first_indexed | 2024-03-07T06:08:42Z |
format | Journal article |
id | oxford-uuid:eeb73dda-ea46-4edd-bc15-c1c570f86d0c |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T06:08:42Z |
publishDate | 2000 |
record_format | dspace |
spelling | oxford-uuid:eeb73dda-ea46-4edd-bc15-c1c570f86d0c2022-03-27T11:34:58ZPseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:eeb73dda-ea46-4edd-bc15-c1c570f86d0cEnglishSymplectic Elements at Oxford2000De Silva, BBanney, LUttley, WLuqmani, RSchofield, OPseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicated in the etiology of this condition. In a 1-year prospective study of children attending the pediatric rheumatology clinic in Edinburgh we found a prevalence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, independent of dosage. Blue/gray eye color was an independent risk factor for the development of pseudoporphyria. We would advise caution in prescribing naproxen in these children to prevent disfiguring facial scarring. |
spellingShingle | De Silva, B Banney, L Uttley, W Luqmani, R Schofield, O Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. |
title | Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. |
title_full | Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. |
title_fullStr | Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. |
title_full_unstemmed | Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. |
title_short | Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis. |
title_sort | pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis |
work_keys_str_mv | AT desilvab pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis AT banneyl pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis AT uttleyw pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis AT luqmanir pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis AT schofieldo pseudoporphyriaandnonsteroidalantiinflammatoryagentsinchildrenwithjuvenileidiopathicarthritis |